PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Clinical trials for PSP - PROGRESSIVE SUPRANUCLEAR PALSY explained in plain language.
Never miss a new study
Get alerted when new PSP - PROGRESSIVE SUPRANUCLEAR PALSY trials appear
Sign up with your email to follow new studies for PSP - PROGRESSIVE SUPRANUCLEAR PALSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PSP: experimental Vaccine-Like drug enters key trial
Disease control Not yet recruitingThis study tests a drug called AADvac1 in people with progressive supranuclear palsy (PSP), a rare brain disease that affects movement and balance. The goal is to see if AADvac1 can slow down the disease. About 146 participants with early-stage PSP will receive the drug or a plac…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for rare brain disease: drug trial aims to slow PSP
Disease control Not yet recruitingThis study tests a drug called LM11A-31 in 147 people with Progressive Supranuclear Palsy (PSP), a rare brain disease that affects movement and thinking. The goal is to see if the drug can slow down the disease. Participants will take the drug and be monitored for changes in thei…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 12, 2026 13:43 UTC